Biologically, the prominence of anti-AGR2 suggests that immune recognition of AGR2-expressing tumor cells reflects ER stress-related neoantigen exposure, whereas anti-TYMS responses may correspond to proliferative or DNA repair-linked antigenicity characteristic of early neoplastic transformation. This evidence concerns the gene AGR2 and neoplasm.